PET imaging of α4β2* nicotinic acetylcholine receptors: Quantitative analysis of 18F-nifene kinetics in the nonhuman primate

Journal of Nuclear Medicine

Volumn 53, Issue 9, 2012, Pages 1471-1480

  Hillmer, Ansel T ^a,b   Wooten, Dustin W ^a,b   Slesarev, Maxim S ^b   Ahlers, Elizabeth O ^b   Barnhart, Todd E ^a   Murali, Dhanabalan ^a,b   Schneider, Mary L ^c   Mukherjee, Jogeshwar ^d   Christian, Bradley T ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

18F nifene; Compartment modeling; nAChR; Nicotine; PET

Indexed keywords

FLUORINE 18; NICOTINIC RECEPTOR; RADIOLIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BRAIN REGION; CEREBELLUM; DISTRIBUTION VOLUME; FEMALE; FRONTAL CORTEX; IN VIVO STUDY; KINETICS; LATERAL GENICULATE BODY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHESUS MONKEY; SUBICULUM; THALAMUS;

ANIMALS; ARTERIES; BIOLOGICAL TRANSPORT; CEREBELLUM; FEMALE; KINETICS; MACACA MULATTA; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; PYRROLES; RADIOCHEMISTRY; RECEPTORS, NICOTINIC;

EID: 84866173611     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.103846     Document Type: Article

References (39)

1. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74:363-396.
2. Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry. 2001;49:175-184.
3. Burghaus L, Schütz U, Krempel U, Lindstrom J, Schröder H. Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients. Parkinsonism Relat Disord. 2003;9:243-246.
4. Hellström-Lindahl E, Court JA. Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging. Behav Brain Res. 2000;113:159-168.
5. Scheffer IE, Berkovic SF. The genetics of human epilepsy. Trends Pharmacol Sci. 2003;24:428-433.
6. Poirier M-F, Canceil O, Baylé F, et al. Prevalence of smoking in psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:529-537.
7. Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol. 2004;18:457-474.
8. Baer JS, Sampson PD, Barr HM, Connor PD, Streissguth AP. A 21-year longitudinal analysis of the effects of prenatal alcohol exposure on young adult drinking. Arch Gen Psychiatry. 2003;60:377-385.
9. Muzic RF, Berridge MS, Friedland RP, Zhu N, Nelson AD. PET quantification of specific binding of carbon-11-nicotine in human brain. J Nucl Med. 1998;39:2048-2054.
10. 18F]fluoro-A- 85380. J Nucl Med. 1999;40:1374-1380.
11. 18F- fluoro-A-85380 and PET. J Nucl Med. 2005;46:240-247.
12. 18F]F-A85380. Neuroimage. 2008;39:717-727.
13. 18F]fluoro-A-85380. Synapse. 2009;63:752-763.
14. Kendziorra K, Wolf H, Meyer PM, et al. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging. 2011;38:515-525.
15. Meyer PM, Strecker K, Kendziorra K, et al. Reduced α4β2* -nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch Gen Psychiatry. 2009;66:866-877.
16. Picard F, Bruel D, Servent D, et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain. 2006;129:2047-2060.
17. Horti AG, Gao Y, Kuwabara H, Dannals RF. Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography. Life Sci. 2010;86:575-584.
18. 11C]-raclopride. Synapse. 2004;52:188-208.
19. Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM. Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab. 2010;30:1682-1706.
20. 18F-nifene) in rodents and imaging by PET in non-human primate. Nucl Med Biol. 2006;33:295-304.
21. Hillmer AT, Wooten DW, Moirano JM, et al. Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey. Synapse. 2011;65:1309-1318.
22. Perry DC, Dávila-García MI, Stockmeier CA, Kellar KJ. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther. 1999;289:1545-1552.
23. 18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol. 1998;25:343-350.
24. Tai C, Chatziioannou A, Siegel S, et al. Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol. 2001;46:1845-1862.
25. Christian BT, Vandehey NT, Floberg JM, Mistretta CA. Dynamic PET denoising with HYPR processing. J Nucl Med. 2010;51:1147-1154.
26. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539.
27. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740-747.
28. Muzic RF, Cornelius S. COMKAT: compartment model kinetic analysis tool. J Nucl Med. 2001;42:636-645.
29. Hurvich CM, Tsai C-L. Regression and time series model selection in small samples. Biometrika. 1989;76:297-307.
30. Logan J, Fowler JS, Volkow ND, et al. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.
31. Ichise M, Ballinger JR, Golan H, et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J Nucl Med. 1996;37:513-520.
32. 18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse. 2003;48:25-34.
33. 18F-AZAN, a radioligand with improved brain kinetics. J Nucl Med. 2012;53:121-129.
34. 18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors - in vitro binding properties and PET studies in baboons. J Nucl Med. 2009;50:1349-1355.
35. 18F]Norchloro-fluoro- homoepibatidine. Synapse. 2008;62:205-218.
36. 18F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging. EJNMMI Research. 2011;1:6.
37. 18F-Nifene : a measure of acetylcholine competition. Synapse. 2007;61:29-36.
38. 18F] fluoro-A-85380 and the multi-injection approach. J Cereb Blood Flow Metab. 2008;28:172-189.
39. Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science. 1986;231:258-261.